Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidates.


Journal

NPJ genomic medicine
ISSN: 2056-7944
Titre abrégé: NPJ Genom Med
Pays: England
ID NLM: 101685193

Informations de publication

Date de publication:
22 Mar 2024
Historique:
received: 20 10 2023
accepted: 27 02 2024
medline: 23 3 2024
pubmed: 23 3 2024
entrez: 23 3 2024
Statut: epublish

Résumé

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with a strong genetic component in which rare variants contribute significantly to risk. We performed whole genome and/or exome sequencing (WGS and WES) and SNP-array analysis to identify both rare sequence and copy number variants (SNVs and CNVs) in 435 individuals from 116 ASD families. We identified 37 rare potentially damaging de novo SNVs (pdSNVs) in the cases (n = 144). Interestingly, two of them (one stop-gain and one missense variant) occurred in the same gene, BRSK2. Moreover, the identification of 8 severe de novo pdSNVs in genes not previously implicated in ASD (AGPAT3, IRX5, MGAT5B, RAB8B, RAP1A, RASAL2, SLC9A1, YME1L1) highlighted promising candidates. Potentially damaging CNVs (pdCNVs) provided support to the involvement of inherited variants in PHF3, NEGR1, TIAM1 and HOMER1 in neurodevelopmental disorders (NDD), although mostly acting as susceptibility factors with incomplete penetrance. Interpretation of identified pdSNVs/pdCNVs according to the ACMG guidelines led to a molecular diagnosis in 19/144 cases, although this figure represents a lower limit and is expected to increase thanks to further clarification of the role of likely pathogenic variants in ASD/NDD candidate genes not yet established. In conclusion, our study highlights promising ASD candidate genes and contributes to characterize the allelic diversity, mode of inheritance and phenotypic impact of de novo and inherited risk variants in ASD/NDD genes.

Identifiants

pubmed: 38519481
doi: 10.1038/s41525-024-00411-1
pii: 10.1038/s41525-024-00411-1
doi:

Types de publication

Journal Article

Langues

eng

Pagination

21

Subventions

Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : GR-2013-02357561
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : GR-2013-02357561
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : GR-2013-02357561
Organisme : U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI)
ID : 3UM1HG008901

Informations de copyright

© 2024. The Author(s).

Références

Lord, C. et al. Autism spectrum disorder. Nat. Rev. Dis. Primers 6, 1–23 (2020).
doi: 10.1038/s41572-019-0138-4
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet 51, 431–444 (2019).
pubmed: 30804558 pmcid: 6454898 doi: 10.1038/s41588-019-0344-8
Tammimies, K. et al. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. Jama 314, 895–903 (2015).
pubmed: 26325558 doi: 10.1001/jama.2015.10078
Satterstrom, F. K. et al. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell 180, 568–584.e523 (2020).
pubmed: 31981491 pmcid: 7250485 doi: 10.1016/j.cell.2019.12.036
Fu, J. M. et al. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat. Genet. 54, 1320–1331 (2022).
pubmed: 35982160 pmcid: 9653013 doi: 10.1038/s41588-022-01104-0
Trost, B. et al. Genomic architecture of autism from comprehensive whole-genome sequence annotation. Cell 185, 4409–4427.e4418 (2022).
pubmed: 36368308 pmcid: 10726699 doi: 10.1016/j.cell.2022.10.009
Wilfert, A. B. et al. Recent ultra-rare inherited variants implicate new autism candidate risk genes. Nat. Genet. 53, 1125–1134 (2021).
pubmed: 34312540 pmcid: 8459613 doi: 10.1038/s41588-021-00899-8
Zhou, X. et al. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. Nat. Genet. 54, 1305–1319 (2022).
pubmed: 35982159 pmcid: 9470534 doi: 10.1038/s41588-022-01148-2
Pinto, D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368–372 (2010).
pubmed: 20531469 pmcid: 3021798 doi: 10.1038/nature09146
Moreno-De-Luca, D. et al. Using large clinical data sets to infer pathogenicity for rare copy number variants in autism cohorts. Mol. Psychiatry 18, 1090–1095 (2013).
pubmed: 23044707 doi: 10.1038/mp.2012.138
Zarrei, M. et al. A large data resource of genomic copy number variation across neurodevelopmental disorders. NPJ Genom. Med. 4, 26 (2019).
pubmed: 31602316 pmcid: 6779875 doi: 10.1038/s41525-019-0098-3
Rochat, M. J. et al. Brain Magnetic Resonance Findings in 117 Children with Autism Spectrum Disorder under 5 Years Old. Brain Sci. 10 (2020).
Skuse, D. H., Mandy, W. P. & Scourfield, J. Measuring autistic traits: heritability, reliability and validity of the Social and Communication Disorders Checklist. Br. J. Psychiatry 187, 568–572 (2005).
pubmed: 16319410 doi: 10.1192/bjp.187.6.568
Hurley, R. S., Losh, M., Parlier, M., Reznick, J. S. & Piven, J. The broad autism phenotype questionnaire. J. Autism. Dev. Disord. 37, 1679–1690 (2007).
pubmed: 17146701 doi: 10.1007/s10803-006-0299-3
Caporali, L. et al. Dissecting the multifaceted contribution of the mitochondrial genome to autism spectrum disorder. Front. Genet. 13, 953762 (2022).
pubmed: 36419830 pmcid: 9676943 doi: 10.3389/fgene.2022.953762
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
pubmed: 32461654 pmcid: 7334197 doi: 10.1038/s41586-020-2308-7
Samocha, K. E. et al. Regional missense constraint improves variant deleteriousness prediction. bioRxiv, https://doi.org/10.1101/148353 (2017).
Cummings, B. B. et al. Transcript expression-aware annotation improves rare variant interpretation. Nature 581, 452–458 (2020).
pubmed: 32461655 pmcid: 7334198 doi: 10.1038/s41586-020-2329-2
Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).
pubmed: 37733863 doi: 10.1126/science.adg7492
Koopmans, F. et al. SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse. Neuron 103, 217–234.e214 (2019).
pubmed: 31171447 pmcid: 6764089 doi: 10.1016/j.neuron.2019.05.002
Leblond, C. S. et al. Operative list of genes associated with autism and neurodevelopmental disorders based on database review. Mol Cell Neurosci. 113, 103623 (2021).
pubmed: 33932580 doi: 10.1016/j.mcn.2021.103623
Collins, R. L. et al. A cross-disorder dosage sensitivity map of the human genome. Cell 185, 3041–3055.e3025 (2022).
pubmed: 35917817 pmcid: 9742861 doi: 10.1016/j.cell.2022.06.036
Priolo, M. et al. Further delineation of Malan syndrome. Hum. Mutat. 39, 1226–1237 (2018).
pubmed: 29897170 pmcid: 6175110 doi: 10.1002/humu.23563
Riglin, L. et al. Variable Emergence of Autism Spectrum Disorder Symptoms From Childhood to Early Adulthood. Am. J. Psychiatry 178, 752–760 (2021).
pubmed: 33900814 pmcid: 7611492 doi: 10.1176/appi.ajp.2020.20071119
Amabile, S. et al. DYNC1H1-related disorders: A description of four new unrelated patients and a comprehensive review of previously reported variants. Am. J. Med. Genet. A 182, 2049–2057 (2020).
pubmed: 32656949 doi: 10.1002/ajmg.a.61729
Iwama, K. et al. A novel SLC9A1 mutation causes cerebellar ataxia. J. Hum. Genet. 63, 1049–1054 (2018).
pubmed: 30018422 doi: 10.1038/s10038-018-0488-x
Hesarur, N. et al. Lichtenstein-Knorr Syndrome: A Rare Case of Ataxia with Sensorineural Hearing Loss. Ann. Indian. Acad. Neurol. 25, 970–973 (2022).
pubmed: 36561016 pmcid: 9764880 doi: 10.4103/aian.aian_288_22
Guissart, C. et al. Mutation of SLC9A1, encoding the major Na
pubmed: 25205112 doi: 10.1093/hmg/ddu461
Zhu, X. et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet. Med. 17, 774–781 (2015).
pubmed: 25590979 pmcid: 4791490 doi: 10.1038/gim.2014.191
Li, X. & Fliegel, L. A novel human mutation in the SLC9A1 gene results in abolition of Na+/H+ exchanger activity. PLoS One 10, e0119453 (2015).
pubmed: 25760855 pmcid: 4356549 doi: 10.1371/journal.pone.0119453
Bögershausen, N. et al. RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome. J. Clin. Invest. 125, 3585–3599 (2015).
pubmed: 26280580 pmcid: 4588287 doi: 10.1172/JCI80102
Hiatt, S. M. et al. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder. Am. J. Hum. Genet. 104, 701–708 (2019).
pubmed: 30879638 pmcid: 6451696 doi: 10.1016/j.ajhg.2019.02.002
Feliciano, P. et al. Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. NPJ Genom. Med. 4, 19 (2019).
pubmed: 31452935 pmcid: 6707204 doi: 10.1038/s41525-019-0093-8
De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209–215 (2014).
pubmed: 25363760 pmcid: 4402723 doi: 10.1038/nature13772
Mahjani, B. et al. Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder. Mol. Autism. 12, 65 (2021).
pubmed: 34615535 pmcid: 8495954 doi: 10.1186/s13229-021-00465-3
Costa, C. I. S. et al. Three generation families: Analysis of de novo variants in autism. Eur. J. Hum. Genet. (2023).
Nakanishi, K. et al. Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex. Cereb. Cortex 29, 3738–3751 (2019).
pubmed: 30307479 doi: 10.1093/cercor/bhy253
Deng, J. et al. Deleterious Variation in BR Serine/Threonine Kinase 2 Classified a Subtype of Autism. Front. Mol. Neurosci. 15, 904935 (2022).
pubmed: 35754711 pmcid: 9231588 doi: 10.3389/fnmol.2022.904935
Appel, L. M. et al. PHF3 regulates neuronal gene expression through the Pol II CTD reader domain SPOC. Nat. Commun. 12, 6078 (2021).
pubmed: 34667177 pmcid: 8526623 doi: 10.1038/s41467-021-26360-2
Genovese, A., Cox, D. M. & Butler, M. G. Partial Deletion of Chromosome 1p31.1 Including only the Neuronal Growth Regulator 1 Gene in Two Siblings. J. Pediatr. Genet. 4, 23–28 (2015).
pubmed: 27617112 pmcid: 4906414 doi: 10.1055/s-0035-1554977
Tassano, E. et al. 1p31.1 microdeletion including only NEGR1 gene in two patients. Eur. J. Med. Genet. 63, 103919 (2020).
pubmed: 32209393 doi: 10.1016/j.ejmg.2020.103919
Kubick, N., Brösamle, D. & Mickael, M. E. Molecular Evolution and Functional Divergence of the IgLON Family. Evol. Bioinform. Online 14, 1176934318775081 (2018).
pubmed: 29844654 pmcid: 5967153 doi: 10.1177/1176934318775081
Szczurkowska, J. et al. NEGR1 and FGFR2 cooperatively regulate cortical development and core behaviours related to autism disorders in mice. Brain 141, 2772–2794 (2018).
pubmed: 30059965 pmcid: 6113639
Singh, K. et al. Neuronal Growth and Behavioral Alterations in Mice Deficient for the Psychiatric Disease-Associated. Front. Mol. Neurosci. 11, 30 (2018).
pubmed: 29479305 pmcid: 5811522 doi: 10.3389/fnmol.2018.00030
Lu, S. et al. Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability, and seizures. Am. J. Hum. Genet. 109, 571–586 (2022).
pubmed: 35240055 pmcid: 9069076 doi: 10.1016/j.ajhg.2022.01.020
Stillman, M., Lautz, J. D., Johnson, R. S., MacCoss, M. J. & Smith, S. E. P. Activity dependent dissociation of the Homer1 interactome. Sci. Rep. 12, 3207 (2022).
pubmed: 35217690 pmcid: 8881602 doi: 10.1038/s41598-022-07179-3
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
pubmed: 25741868 pmcid: 4544753 doi: 10.1038/gim.2015.30
Macchiaiolo, M. et al. A deep phenotyping experience: up to date in management and diagnosis of Malan syndrome in a single center surveillance report. Orphanet. J. Rare Dis 17, 235 (2022).
pubmed: 35717370 pmcid: 9206304 doi: 10.1186/s13023-022-02384-9
Robinson, E. B. et al. Autism spectrum disorder severity reflects the average contribution of de novo and familial influences. Proc. Natl. Acad. Sci. USA 111, 15161–15165 (2014).
pubmed: 25288738 pmcid: 4210299 doi: 10.1073/pnas.1409204111
Weiner, D. J. et al. Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nat. Genet. 49, 978–985 (2017).
pubmed: 28504703 pmcid: 5552240 doi: 10.1038/ng.3863
American Psychiatric Association, DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5™ (5th ed.). (American Psychiatry Association, Washington, D.C., 2013).
Lord, C. et al. (ADOS®-2) Autism Diagnostic Observation Schedule™, Second Edition (Western Psychological Services, Torrance, CA, USA, 2012).
Schopler, E., Van Bourgondien, M. E., Wellman, G. J., & Love, S. R. The Childhood Autism Rating Scale (2nd ed.) (CARS2). (Los Angeles, CA: Western Psychological Services, 2010).
Sparrow, S. S., Cicchetti, D. V., Saulnier, C. A. Vineland Adaptive Behavior Scales. (Pearson, San Antonio,TX, ed. Third, 2016).
Ozonoff, S., Heung, K., Byrd, R., Hansen, R. & Hertz-Picciotto, I. The onset of autism: patterns of symptom emergence in the first years of life. Autism Res 1, 320–328 (2008).
pubmed: 19360687 pmcid: 2857525 doi: 10.1002/aur.53
Sasson, N. J. et al. The broad autism phenotype questionnaire: prevalence and diagnostic classification. Autism Res 6, 134–143 (2013).
pubmed: 23427091 pmcid: 3661685 doi: 10.1002/aur.1272
Anderson, C. A. et al. Data quality control in genetic case-control association studies. Nat. Protoc. 5, 1564–1573 (2010).
pubmed: 21085122 pmcid: 3025522 doi: 10.1038/nprot.2010.116
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Chiara, M. et al. CoVaCS: a consensus variant calling system. BMC Genom. 19, 120 (2018).
doi: 10.1186/s12864-018-4508-1
Regier, A. A. et al. Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects. Nat. Commun. 9, 8 (2018).
doi: 10.1038/s41467-018-06159-4
Heng, L. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. (arXiv:1303.3997v2 [q-bio.GN], 2013).
DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491–498 (2011).
pubmed: 21478889 pmcid: 3083463 doi: 10.1038/ng.806
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38, e164 (2010).
pubmed: 20601685 pmcid: 2938201 doi: 10.1093/nar/gkq603
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
pubmed: 21221095 pmcid: 3346182 doi: 10.1038/nbt.1754
Choi, S. W., Mak, T. S.-H. & O’Reilly, P. F. Tutorial: a guide to performing polygenic risk score analyses. Nat. Protoc. 15, 2759–2772 (2020).
pubmed: 32709988 pmcid: 7612115 doi: 10.1038/s41596-020-0353-1
Bacchelli, E. et al. An integrated analysis of rare CNV and exome variation in Autism Spectrum Disorder using the Infinium PsychArray. Sci. Rep. 10, 3198 (2020).
pubmed: 32081867 pmcid: 7035424 doi: 10.1038/s41598-020-59922-3
Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome. Res. 17, 1665–1674 (2007).
pubmed: 17921354 pmcid: 2045149 doi: 10.1101/gr.6861907
Colella, S. et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res 35, 2013–2025 (2007).
pubmed: 17341461 pmcid: 1874617 doi: 10.1093/nar/gkm076
Douard, E. et al. Effect Sizes of Deletions and Duplications on Autism Risk Across the Genome. Am. J. Psychiatry 178, 87–98 (2021).
pubmed: 32911998 doi: 10.1176/appi.ajp.2020.19080834
Zarrei, M., MacDonald, J. R., Merico, D. & Scherer, S. W. A copy number variation map of the human genome. Nat. Rev. Genet. 16, 172–183 (2015).
pubmed: 25645873 doi: 10.1038/nrg3871
Roller, E., Ivakhno, S., Lee, S., Royce, T. & Tanner, S. Canvas: versatile and scalable detection of copy number variants. Bioinformatics 32, 2375–2377 (2016).
pubmed: 27153601 doi: 10.1093/bioinformatics/btw163

Auteurs

Marta Viggiano (M)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Fabiola Ceroni (F)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.

Paola Visconti (P)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy.

Annio Posar (A)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Maria Cristina Scaduto (MC)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy.

Laura Sandoni (L)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Irene Baravelli (I)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Cinzia Cameli (C)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Magali J Rochat (MJ)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Functional and Molecular Neuroimaging Unit, Bologna, Italy.

Alessandra Maresca (A)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy.

Alessandro Vaisfeld (A)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Davide Gentilini (D)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Bioinformatics and Statistical Genomic Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Luciano Calzari (L)

Bioinformatics and Statistical Genomic Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Valerio Carelli (V)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy.

Michael C Zody (MC)

New York Genome Center (NYGC), New York, NY, USA.

Elena Maestrini (E)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. elena.maestrini@unibo.it.

Elena Bacchelli (E)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. elena.bacchelli@unibo.it.

Classifications MeSH